Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
- PMID:27911317
- DOI: 10.3233/JAD-160884
Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State
Abstract
Alzheimer's disease (AD) is a neurodegenerative brain disease and is the most common form of dementia. In recent years, many studies indicated the association of gut microbiota changes with metabolic diseases. However, the gut microbiota of AD has not been investigated. The present study aims to compare the gut microbiota in APP/PS1 transgenic mice of AD and C57/Bl6 wild-type (WT) mice by pyrosequencing the V3 and V4 regions of the bacterial 16S ribosomal RNA genes. The 3-, 6-, and 8-month-old APP/PS1 and WT mice were used to explore the effects of age on the gut microbiota. First, the results indicated that impaired spatial learning and memory appeared in 6-month-old APP/PS1 mice and was further aggravated in the 8-month-old group, which was consistent with immunohistochemical studies of amyloid plaque. Second, AD histological and behavioral manifestations in the APP/PS1 mice were found to be correlated with a specific gut microbiome state. Third, the microbiota diversity of APP/PS1 mice decreased with increased age. Fourth, further inspection showed that the abundance of Helicobacteraceae and Desulfovibrionaceae at the family level and Odoribacter and Helicobacter at the genus level increased significantly in APP/PS1 mice than in WT mice, while Prevotella abundance in WT mice was significantly higher than in APP/PS1 mice. More human studies are warranted to explore the potential of gut microbiota as diagnostic biomarkers or therapeutic target for AD.
Keywords: 16S ribosomal RNA; APP/PS1 mice; Alzheimer’s disease; gut microbiota.
Similar articles
- Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.Lok K, Zhao H, Zhang C, He N, Shen H, Wang Z, Zhao W, Yin M.Lok K, et al.J Neurol Sci. 2013 Dec 15;335(1-2):145-54. doi: 10.1016/j.jns.2013.09.018. Epub 2013 Sep 21.J Neurol Sci. 2013.PMID:24095271
- Jatrorrhizine Balances the Gut Microbiota and Reverses Learning and Memory Deficits in APP/PS1 transgenic mice.Wang S, Jiang W, Ouyang T, Shen XY, Wang F, Qu YH, Zhang M, Luo T, Wang HQ.Wang S, et al.Sci Rep. 2019 Dec 20;9(1):19575. doi: 10.1038/s41598-019-56149-9.Sci Rep. 2019.PMID:31862965Free PMC article.
- MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX, Chen DF.Li F, et al.Brain Res. 2015 Nov 19;1627:177-88. doi: 10.1016/j.brainres.2015.09.022. Epub 2015 Sep 28.Brain Res. 2015.PMID:26423933
- Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.Kesika P, Suganthy N, Sivamaruthi BS, Chaiyasut C.Kesika P, et al.Life Sci. 2021 Jan 1;264:118627. doi: 10.1016/j.lfs.2020.118627. Epub 2020 Oct 22.Life Sci. 2021.PMID:33169684Review.
- The Gut Microbiota and Alzheimer's Disease.Jiang C, Li G, Huang P, Liu Z, Zhao B.Jiang C, et al.J Alzheimers Dis. 2017;58(1):1-15. doi: 10.3233/JAD-161141.J Alzheimers Dis. 2017.PMID:28372330Review.
Cited by
- Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the gut microbiota.Zhang Y, Ding N, Hao X, Zhao J, Zhao Y, Li Y, Li Z.Zhang Y, et al.Front Aging Neurosci. 2022 Oct 13;14:1018371. doi: 10.3389/fnagi.2022.1018371. eCollection 2022.Front Aging Neurosci. 2022.PMID:36313024Free PMC article.
- Gut microbiome alterations in preclinical Alzheimer's disease.Jung JH, Kim G, Byun MS, Lee JH, Yi D, Park H, Lee DY; KBASE Research Group.Jung JH, et al.PLoS One. 2022 Nov 29;17(11):e0278276. doi: 10.1371/journal.pone.0278276. eCollection 2022.PLoS One. 2022.PMID:36445883Free PMC article.
- Sex and Gender Differences in Alzheimer's Disease: Genetic, Hormonal, and Inflammation Impacts.Kolahchi Z, Henkel N, Eladawi MA, Villarreal EC, Kandimalla P, Lundh A, McCullumsmith RE, Cuevas E.Kolahchi Z, et al.Int J Mol Sci. 2024 Aug 3;25(15):8485. doi: 10.3390/ijms25158485.Int J Mol Sci. 2024.PMID:39126053Free PMC article.Review.
- High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?Valentin-Escalera J, Leclerc M, Calon F.Valentin-Escalera J, et al.J Alzheimers Dis. 2024;97(3):977-1005. doi: 10.3233/JAD-230118.J Alzheimers Dis. 2024.PMID:38217592Free PMC article.Review.
- Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer's disease via modulating neuropathology and gut microbiota through suppressing C/EBPβ/AEP pathway.Xu QQ, Su ZR, Yang W, Zhong M, Xian YF, Lin ZX.Xu QQ, et al.J Neuroinflammation. 2023 Jan 30;20(1):19. doi: 10.1186/s12974-023-02704-1.J Neuroinflammation. 2023.PMID:36717922Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical